New research led by Oregon Health & Science University reveals a promising approach to developing a universal influenza vaccine—a so-called “one and done” vaccine that confers lifetime immunity against an evolving virus.

Anaconda Biomed S.L., a medical technology company developing next-generation thrombectomy systems, has announced that it has received conditional IDE approval from the U.S. Food and Drug Administration to begin the ATHENA study of its ANA Funnel Catheter.

EKF Diagnostics Holdings, the AIM-listed global diagnostics business, has announced the launch of its new Biosen C-Line (Biosen), an advanced version of its industry leading rapid benchtop glucose and lactate analyser.

Inspire Medical Systems (NYSE: INSP)+ announced today that its Inspire therapy has secured its CE mark under the EU’s Medical Device Regulation.